Clinical Trial: Study to Evaluate the Effect of Aficamten Administration on QT/QTc Interval
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Healthy Participants
Study Type: INTERVENTIONAL
Official Title: A Randomized, 2-Part, Single-Dose, Crossover Study to Evaluate the Effect of Aficamten Administration on QT/QTc Interval in Healthy Participants
Brief Summary:
This is a single-center, 2-part (Part A and Part B) study in healthy participants.Part A (Dose Finding) is an open-label, SAD study to identify the dose for Part B. Part B (TQT Study) is a randomized, double-blind (with respect to aficamten and matching placebo), positive- and placebo-controlled, single-dose, 3-way crossover study to evaluate the effect of aficamten administration on QT/QTc interval.
Read more